Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kuzmits

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Wiener Klinische Wochenschrift|June 9, 1989
[Cholesterol screening in a bank for the detection of a risk population]J Flores, H Richter, K Weiss, et al.
Wiener Klinische Wochenschrift|May 24, 1985
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]C C Zielinski, R Kuzmits, E Kubista, et al.
Onkologie|August 1, 1988
[Interferon therapy in multiple myeloma]H Ludwig, W Scheithauer, I Kührer, et al.
Acta Medica Austriaca|January 1, 1985
[Interferon in the treatment of multiple myeloma]R Kuzmits, H Ludwig, A Cortelezzi, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1986
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialH Ludwig, A Cortelezzi, W Scheithauer, et al.
Oncology|January 1, 1985
Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseasesH Ludwig, A Cortelezzi, B G Van Camp, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Wiener Klinische Wochenschrift|June 9, 1989
[Cholesterol screening in a bank for the detection of a risk population]J Flores, H Richter, K Weiss, et al.
Wiener Klinische Wochenschrift|May 24, 1985
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]C C Zielinski, R Kuzmits, E Kubista, et al.
Onkologie|August 1, 1988
[Interferon therapy in multiple myeloma]H Ludwig, W Scheithauer, I Kührer, et al.
Acta Medica Austriaca|January 1, 1985
[Interferon in the treatment of multiple myeloma]R Kuzmits, H Ludwig, A Cortelezzi, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1986
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialH Ludwig, A Cortelezzi, W Scheithauer, et al.
Oncology|January 1, 1985
Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseasesH Ludwig, A Cortelezzi, B G Van Camp, et al.
Pageof 4